A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia (CME)

Transfusion

Volumn 52, Issue 11, 2012, Pages 2466-2474

  Webert, Kathryn E ^a   Arnold, Donald M ^a   Lui, Yang ^a   Carruthers, Julie ^a   Arnold, Emmy ^a   Heddle, Nancy M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BLEEDING; BLEEDING SEVERITY MEASUREMENT SCALE; CAUSE OF DEATH; CHEMOTHERAPY INDUCED THROMBOCYTOPENIA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRITERION RELATED VALIDITY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEASIBILITY STUDY; HUMAN; INTERNAL VALIDITY; INTERRATER RELIABILITY; INTRARATER RELIABILITY; MEASUREMENT; MEDICAL EXPERT; MORBIDITY; PILOT STUDY; PSYCHOMETRY; RATING SCALE; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS; EDUCATION, MEDICAL, CONTINUING; ELECTRONIC MAIL; HEALTH SURVEYS; HEMORRHAGE; HEMOSTATICS; HUMANS; MORBIDITY; NEOPLASMS; OBSERVER VARIATION; PLATELET TRANSFUSION; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA;

EID: 84869213314     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03634.x     Document Type: Article

References (17)

1. National Cancer Institute. Common Toxicity Critera for Adverse Events (CTCAE). Version 4.0. 2009.
2. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP,. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-55.
3. Miller AB, Hoogstraten B, Staquet M, Winkler A,. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
4. Heddle NM, Cook RJ, Webert KE, Sigouin C, Rebulla P,; Biomedical Excellence for Safer Transfusion Working Party of the International Society for Blood Transfusion. Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. Transfusion 2003; 43: 742-52.
5. Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G, Barbui T, Mandelli F, Sirchia G,. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 1997; 337: 1870-5.
6. Heddle NM, Cook RJ, Tinmouth A, Kouroukis CT, Hervig T, Klapper E, Brandwein JM, Szczepiorkowski ZM, AuBuchon JP, Barty RL, Lee KA,; SToP Study Investigators of the BEST Collaborative. A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood 2009; 113: 1564-73.
7. Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, Konkle BA, Woodson RD, Ortel TL, Hillyer CD, Skerrett DL, McCrae KR, Sloan SR, Uhl L, George JN, Aquino VM, Manno CS, McFarland JG, Hess JR, Leissinger C, Granger S,. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010; 362: 600-13.
8. Heddle NM, Wu C, Vassallo R, Carey P, Arnold D, Lozano M, Pavenski K, Sweeney J, Stanworth S, Liu Y, Traore A, Barty R, Tinmouth A,; BEST Collaborative. Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges. Transfusion 2011; 51: 2304-10.
9. Koreth R, Weinert C, Weisdorf DJ, Key NS,. Measurement of bleeding severity: a critical review. Transfusion 2004; 44: 605-17.
10. Heddle NM, Arnold DM, Webert KE,. Time to rethink clinically important outcomes in platelet transfusion trials. Transfusion 2011; 51: 430-4.
11. Guyatt GH, Bombardier C, Tugwell PX,. Measuring disease-specific quality of life in clinical trials. CMAJ 1986; 134: 889-95.
12. Webert KE, Arnold E, Barty R, Traore A, Arnold DM,. The development of a Bleeding Severity Measurement Scale (BSMS): a new measurement tool. Transfusion 2009; 49 (Suppl): 165A.
13. Streiner DL, Norman GR,. Health measurement scales: a practical guide to their development and use. New York: Oxford University Press; 2008.
14. Kirshner B, Guyatt G,. A methodological framework for assessing health indices. J Chronic Dis 1985; 38: 27-36.
15. Jacobson SF,. Evaluating instruments for use in clinical nursing research. In:, Frank-Stromborg M, Olsen S, editors. Instruments for clinical health research. East Norwalk (CT): Appleton and Lange; 1988. p. 3-19.
16. Shrout PE, Fleiss JL,. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 420-8.
17. Walter SD, Eliasziw M, Donner A,. Sample size and optimal designs for reliability studies. Stat Med 1998; 17: 101-10.